387 related articles for article (PubMed ID: 19116244)
1. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
[TBL] [Abstract][Full Text] [Related]
2. SUMO-specific protease 1 modulates cadmium-augmented transcriptional activity of androgen receptor (AR) by reversing AR SUMOylation.
Wu R; Cui Y; Yuan X; Yuan H; Wang Y; He J; Zhao J; Peng S
Toxicol Lett; 2014 Sep; 229(2):405-13. PubMed ID: 25014244
[TBL] [Abstract][Full Text] [Related]
3. Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells.
Bawa-Khalfe T; Cheng J; Wang Z; Yeh ET
J Biol Chem; 2007 Dec; 282(52):37341-9. PubMed ID: 17932034
[TBL] [Abstract][Full Text] [Related]
4. Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus.
Rytinki M; Kaikkonen S; Sutinen P; Paakinaho V; Rahkama V; Palvimo JJ
Mol Cell Biol; 2012 Oct; 32(20):4195-205. PubMed ID: 22890844
[TBL] [Abstract][Full Text] [Related]
5. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1.
Cheng J; Wang D; Wang Z; Yeh ET
Mol Cell Biol; 2004 Jul; 24(13):6021-8. PubMed ID: 15199155
[TBL] [Abstract][Full Text] [Related]
6. Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation.
Sutinen P; Rahkama V; Rytinki M; Palvimo JJ
Mol Endocrinol; 2014 Oct; 28(10):1719-28. PubMed ID: 25127374
[TBL] [Abstract][Full Text] [Related]
7. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
[TBL] [Abstract][Full Text] [Related]
8. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
[TBL] [Abstract][Full Text] [Related]
9. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka A; Morawiec Z; Wozniak K
Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
[TBL] [Abstract][Full Text] [Related]
10. Analysis of androgen receptor SUMOylation.
Rytinki MM; Kaikkonen S; Sutinen P; Palvimo JJ
Methods Mol Biol; 2011; 776():183-97. PubMed ID: 21796528
[TBL] [Abstract][Full Text] [Related]
11. SUMO-3 enhances androgen receptor transcriptional activity through a sumoylation-independent mechanism in prostate cancer cells.
Zheng Z; Cai C; Omwancha J; Chen SY; Baslan T; Shemshedini L
J Biol Chem; 2006 Feb; 281(7):4002-12. PubMed ID: 16361251
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the SENP1 mutant C603S-SUMO complex reveals the hydrolytic mechanism of SUMO-specific protease.
Xu Z; Chau SF; Lam KH; Chan HY; Ng TB; Au SW
Biochem J; 2006 Sep; 398(3):345-52. PubMed ID: 16712526
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1.
Bailey D; O'Hare P
J Biol Chem; 2004 Jan; 279(1):692-703. PubMed ID: 14563852
[TBL] [Abstract][Full Text] [Related]
14. The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.
Chauhan KM; Chen Y; Chen Y; Liu AT; Sun XX; Dai MS
J Cell Biochem; 2021 Feb; 122(2):189-197. PubMed ID: 32786121
[TBL] [Abstract][Full Text] [Related]
15. Two distinct sites in Nup153 mediate interaction with the SUMO proteases SENP1 and SENP2.
Chow KH; Elgort S; Dasso M; Ullman KS
Nucleus; 2012 Jul; 3(4):349-58. PubMed ID: 22688647
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells.
Kaikkonen S; Paakinaho V; Sutinen P; Levonen AL; Palvimo JJ
Mol Endocrinol; 2013 Feb; 27(2):212-23. PubMed ID: 23192983
[TBL] [Abstract][Full Text] [Related]
17. Small ubiquitin-like modifier protein-specific protease 1 and prostate cancer.
Zuo Y; Cheng JK
Asian J Androl; 2009 Jan; 11(1):36-8. PubMed ID: 19050680
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
[TBL] [Abstract][Full Text] [Related]
19. SUMO modification modulates the activity of calpain-2.
Wang HC; Huang YS; Ho CC; Jeng JC; Shih HM
Biochem Biophys Res Commun; 2009 Jul; 384(4):444-9. PubMed ID: 19422794
[TBL] [Abstract][Full Text] [Related]
20. The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression.
Rodríguez-Castañeda F; Lemma RB; Cuervo I; Bengtsen M; Moen LM; Ledsaak M; Eskeland R; Gabrielsen OS
J Biol Chem; 2018 Oct; 293(40):15439-15454. PubMed ID: 30082317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
